ROWATINEX Pinene / Camphene / Cineol / Fenchone / Borneol / Anethol / Olive Oil 31mg / 15mg / 3mg / 4mg / 10mg / 4mg / 33mg Capsule 1's
RXDRUG-DR-XY23131-1pc
- View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
RXDRUG-DR-XY23131-1pc
|
In stock
|
₱2803 |
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Sellers of this product
Features
Brand
Rowatinex
Full Details
Dosage Strength
31mg / 15mg / 3mg / 4mg / 10mg / 4mg / 33mg
Drug Ingredients
- Anethol
- Borneol
- Camphene
- Cineol
- Fenchone
- Olive Oil
- Pinene
Drug Packaging
Capsule 1's
Generic Name
Pinene / Camphene / Cineol / Fenchone / Borneol / Anethol / Olive Oil /
Dosage Form
Capsule
Registration Number
DR-XY23131
Drug Classification
Prescription Drug (RX)
Description
Indications/Uses
For renal and urinary disorders including urolithiasis.
Dosage/Direction for Use
Adults: Unless otherwise directed by the physician, the usual dose is 1-2 capsules three times daily before meals.
Children 6-14 years: Unless otherwise directed by the physician, the usual dose is one capsule twice daily before meals.
Children 6-14 years: Unless otherwise directed by the physician, the usual dose is one capsule twice daily before meals.
Administration
Should be taken on an empty stomach.
Special Precautions
Liquid intake should be increased during therapy.
Although no teratogenic effects have been reported, ROWATINEX should not be given in the first trimester of pregnancy.
Although no teratogenic effects have been reported, ROWATINEX should not be given in the first trimester of pregnancy.
Use In Pregnancy & Lactation
Although no teratogenic effects have been reported, ROWATINEX should not be given in the first trimester of pregnancy.
Storage
Although no teratogenic effects have been reported, ROWATINEX should not be given in the first trimester of pregnancy.
Action
Pharmacology: Mode of Action: ROWATINEX promotes diuresis and relaxes urinary tract spasm, thus assisting the passage of stones. The therapeutic effect of the balanced combination of terpenes reduces urinary tract inflammation, stimulating renal blood flow through the kidneys and increasing the output of less concentrated urine.
MedsGo Class
Other Drugs Acting on the Genito-Urinary System
Please sign in so that we can notify you about a reply